ClinicalTrials.Veeva

Menu

Search for Genetic Basis of Vulvodynia

W

Western Galilee Hospital-Nahariya

Status

Completed

Conditions

Vulvodynia

Study type

Observational

Funder types

Other

Identifiers

NCT01664962
920080002

Details and patient eligibility

About

The purpose of this study is to investigate the possibility of an association between Localized Provoked Vulvodynia (LPV) that is both severe and primary and polymorphic markers/single nucleotide polymorphisms (SNPs) in and around the genes encoding heparanase (HSPE-1), Vanilloid Receptor VR1 (TRPV1), and Nerve Growth Factor (NGF).

Full description

The short-term goal proposed for the current study was to investigate the possibility of an association between Localized Provoked Vulvodynia (LPV) that is both severe and primary and polymorphic markers/single nucleotide polymorphisms (SNPs) in and around the genes encoding heparanase (HSPE-1), Vanilloid Receptor VR1 (TRPV1), and Nerve Growth Factor (NGF).

Eight polymorphic SNPs in the three different genes suspected to be involved in LPV has been examined as follow:

  1. HSPE gene: Four polymorphic SNPs: rs4693608, rs11099592, rs6856901 and rs4364254 that were found to be informative in the Ashkenazi Jewish population
  2. TRPV1 gene: Two polymorphic SNPs: rs222747 and rs8065080.
  3. NGF gene: A novel T to C SNP in the promoter region at position -198 (rs11102930) and rs6330 which was found to be associated with anxiety-related personality traits and has been suggested to may affect intracellular processing and secretion of NGF.

Enrollment

168 patients

Sex

Female

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:o meeting Friedrich's criteria [50] for vulva vestibulitis syndrome

  • diagnosed by a gynecological examination with LPV
  • diagnosed with a severe degree of the syndrome according to Marinoff [48]
  • classified with the primary type of the syndrome according to an interview
  • with both parents of Ashkenazi origin.

Trial design

168 participants in 2 patient groups

Patients
Description:
Women with severe Vulvodynia
Healthy controls
Description:
Women without vulvodynia

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems